Streetbeat News

Products Services

DJT

The brand valuation of Trump Media Stock (DJT) is declining as Donald Trump no longer relies on Truth Social for communication or DJT stock for influence.

Portfolio Pulse from

November 16, 2024 | 10:00 pm

BSX

Boston Scientific's WATCHMAN FLX™ device shows superior bleeding risk reduction compared to oral anticoagulants in the OPTION trial, while maintaining similar stroke risk reduction for atrial fibrillation patients post-cardiac ablation.

Portfolio Pulse from

November 16, 2024 | 8:30 pm

MAT

Mattel, Inc. announced the 2024 winner of the Hot Wheels Legends Tour, a home-built race car named La Liebre, which will be turned into a Hot Wheels die-cast car sold worldwide.

Portfolio Pulse from

November 16, 2024 | 6:45 pm

IMUX

Immunic Inc's IMU-856 shows promise in gastrointestinal health trials, with Phase 1 and Phase 1b results published in The Lancet Gastroenterology & Hepatology.

Portfolio Pulse from

November 16, 2024 | 6:15 pm

AMZN

The technology sector has been a strong performer, consistently delivering substantial returns through growth and innovation. The article suggests two tech stocks to buy and hold for the long term.

Portfolio Pulse from

November 16, 2024 | 5:30 pm

LSTA

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo discussed the company's progress in its pancreatic cancer trial, ASCEND, and its third quarter financial performance. The trial is expected to provide significant data soon.

Portfolio Pulse from

November 16, 2024 | 5:15 pm

FNQQF

Fineqia International Inc reported significant advancements in bridging traditional finance with digital assets, driven by demand for advisory services in tokenization and blockchain integration. The company's third-quarter revenue growth was supported by strategic partnerships.

Portfolio Pulse from

November 16, 2024 | 5:15 pm

MTWO

M2i Global is expanding into cryptocurrency and blockchain technology by utilizing Ethereum as a treasury asset and blockchain platform.

Portfolio Pulse from

November 16, 2024 | 4:00 pm

BMRN

BioMarin Pharmaceutical Inc. presented positive real-world evidence supporting the safety and efficacy of VOXZOGO® (vosoritide) for children with achondroplasia at the ESPE Meeting 2024.

Portfolio Pulse from

November 16, 2024 | 4:00 pm